Minimally Invasive Glaucoma Surgery MIGS Devices Market Report 2025 (Global Edition)

Global Minimally Invasive Glaucoma Surgery MIGS Devices Market Report 2025 Market Size Split by Surgery Outlook: (Glaucoma in Conjunction with Cataract, Stand Alone Glaucoma), by Target Outlook: (Trab...

Minimally Invasive Glaucoma Surgery MIGS Devices Market Report Description

We have various report editions of Minimally Invasive Glaucoma Surgery MIGS Devices Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Competitive Landscape of the Minimally Invasive Glaucoma Surgery - MIGS Devices Market

The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market is highly competitive, with several key players driving innovation and expanding their market presence. Leading companies in the market include Alcon, Glaukos Corporation, Santen Pharmaceutical, and AbbVie, among others. These companies have introduced a range of MIGS devices, such as microstents, trabecular microbypass devices, and implantable drainage devices, offering distinct advantages in terms of safety, efficacy, and patient recovery.

In November 2022, Alcon, Inc. acquired Ivantis, Inc. to develop, manufacture, and sell high-quality Minimally Invasive Glaucoma Surgery (MIGS) devices. (Source: https://www.alcon.com/media-release/alcon-acquire-ivantis-inc-and-its-hydrus-microstent-surgical-glaucoma-strengthening/) In February 2023, Glaukos Corporation received FDA 510 (k) clearance for its product iStent Infinite'. The product is used in a standalone procedure to reduce elevated Intraocular Pressure (IOP) in patients with primary open-angle glaucoma. (Source: https://investors.glaukos.com/investors/news/news-details/2022/Glaukos-Announces-FDA-510k-Clearance-of-iStent-infinite/default.aspx)

Top Companies Market Share in Minimally Invasive Glaucoma Surgery MIGS Devices Industry: (In no particular order of Rank)

• Alcon Inc.
• Glaukos Corporation.
• Johnson & Johnson Vision
• AbbVie Inc. (Allergan Plc.)
• Corza Ophthalmology
• Carl Zeiss Meditec AG
• Katalyst Surgical
• Lumenis Ltd
• Ziemer Ophthalmic Systems AG
• Iridex Corporation
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Minimally Invasive Glaucoma Surgery - MIGS Devices Market

Which Region Dominates the Minimally Invasive Glaucoma Surgery - MIGS Devices Market in 2024?

According to Cognitive Market Research, North America dominates the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market due to its advanced healthcare infrastructure and high adoption of innovative medical technologies. The region has a significant glaucoma patient population, particularly among the aging demographic, driving the demand for effective and less invasive treatment options. Favorable reimbursement policies and widespread health insurance coverage further support the accessibility of MIGS procedures.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is the fastest-growing region in the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market due to its large and aging population, coupled with the increasing prevalence of glaucoma. Rapid urbanization and rising disposable incomes have improved access to advanced healthcare services, fostering demand for minimally invasive procedures.

The current report Scope analyzes Minimally Invasive Glaucoma Surgery MIGS Devices Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America Minimally Invasive Glaucoma Surgery MIGS Devices Market Analysis

According to Cognitive Market Research, the global Minimally Invasive Glaucoma Surgery - MIGS Devices market size was estimated at USD 591.5 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 236.60 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.0% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Minimally Invasive Glaucoma Surgery - MIGS Devices market with a market size of USD 186.68 million in 2024 and is projected to grow at a CAGR of 3.8% during the forecast period. The U.S. market's advanced healthcare infrastructure, high awareness levels.
• The Canada Minimally Invasive Glaucoma Surgery - MIGS Devices market had a market share of USD 28.39 million in 2024 and is projected to grow at a CAGR of 4.8% during the forecast period. Canada’s advanced healthcare infrastructure, high awareness levels.
• The Mexico Minimally Invasive Glaucoma Surgery - MIGS Devices market is projected to witness growth at a CAGR of 4.5% during the forecast period, with a market size of USD 21.53 million in 2024.

Europe Minimally Invasive Glaucoma Surgery MIGS Devices Market Analysis

According to Cognitive Market Research, the global Minimally Invasive Glaucoma Surgery - MIGS Devices market size was estimated at USD 591.5 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 177.45 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.3% from 2024 to 2031.

• The United Kingdom Minimally Invasive Glaucoma Surgery - MIGS Devices market had a market share of USD 29.81 million in 2024 and is projected to grow at a CAGR of 5.1% during the forecast period. In the UK, Minimally Invasive Glaucoma Surgery - MIGS Devices sales witness an upswing due to the robust healthcare systems, increasing prevalence of glaucoma.
• The France Minimally Invasive Glaucoma Surgery - MIGS Devices market is projected to witness growth at a CAGR of 3.5% during the forecast period, with a market size of USD 16.33 million in 2024.
• According to Cognitive Market Research, the German Minimally Invasive Glaucoma Surgery - MIGS Devices market size was valued at USD 35.14 million in 2024 and is projected to grow at a CAGR of 4.5% during the forecast period. In Germany, Minimally Invasive Glaucoma Surgery - MIGS Devices surged due to the robust healthcare systems, increasing prevalence of glaucoma.
• The Italy Minimally Invasive Glaucoma Surgery - MIGS Devices market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD 15.26 million in 2024.
• The Russia Minimally Invasive Glaucoma Surgery - MIGS Devices market is projected to witness growth at a CAGR of 3.3% during the forecast period, with a market size of USD 27.50 million in 2024.
• The Spain Minimally Invasive Glaucoma Surgery - MIGS Devices market is projected to witness growth at a CAGR of 3.4% during the forecast period with a market size of USD 14.55 million in 2024
• The Luxembourg Minimally Invasive Glaucoma Surgery - MIGS Devices market is projected to witness growth at a CAGR of 4.4% during the forecast period, with a market size of USD 5.50 million in 2024.
• The Portugal Minimally Invasive Glaucoma Surgery - MIGS Devices market is projected to witness growth at a CAGR of 4.1% during the forecast period, with a market size of USD 3.73 million in 2024.
• The Greece Minimally Invasive Glaucoma Surgery - MIGS Devices market is projected to witness growth at a CAGR of 4.6% during the forecast period, with a market size of USD 2.13 million in 2024.
• The Rest of Europe's Minimally Invasive Glaucoma Surgery - MIGS Devices market is projected to witness growth at a CAGR of 3.0% during the forecast period, with a market size of USD 27.50 million in 2024.

Asia Pacific Minimally Invasive Glaucoma Surgery MIGS Devices Market Analysis

According to Cognitive Market Research, the global Minimally Invasive Glaucoma Surgery - MIGS Devices market size was estimated at USD 591.5 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 136.05 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.8% from 2024 to 2031.

• According to Cognitive Market Research, the China Minimally Invasive Glaucoma Surgery - MIGS Devices market size was valued at USD 61.22 million in 2024 and is projected to grow at a CAGR of 7.3% during the forecast period. Minimally Invasive Glaucoma Surgery - MIGS Devices surged in China due to rapidly aging population, increasing glaucoma cases.
• The Japan Minimally Invasive Glaucoma Surgery - MIGS Devices market is projected to witness growth at a CAGR of 6.3% during the forecast period, with a market size of USD 18.77 million in 2024.
• The India Minimally Invasive Glaucoma Surgery - MIGS Devices market had a market share of USD 16.33 million in 2024 and is projected to grow at a CAGR of 9.6% during the forecast period. India's rapidly aging population, increasing glaucoma cases.
• The South Korean Minimally Invasive Glaucoma Surgery - MIGS Devices market is projected to witness growth at a CAGR of 6.9% during the forecast period, with a market size of USD 13.60 million in 2024.
• The Australian Minimally Invasive Glaucoma Surgery - MIGS Devices market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 7.07 million in 2024.
• The South East Asia Minimally Invasive Glaucoma Surgery - MIGS Devices market is projected to witness growth at a CAGR of 8.8% during the forecast period, with a market size of USD 9.39 million in 2024.
• The Rest of Asia Pacific Minimally Invasive Glaucoma Surgery - MIGS Devices market is projected to witness growth at a CAGR of 7.6% during the forecast period, with a market size of USD 9.66 million in 2024.

South America Minimally Invasive Glaucoma Surgery MIGS Devices Market Analysis

According to Cognitive Market Research, the global Minimally Invasive Glaucoma Surgery - MIGS Devices market size was estimated at USD 591.5 Million, out of which the Latin America held the market share of around 5% of the global revenue with a market size of USD 29.58 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Minimally Invasive Glaucoma Surgery - MIGS Devices market size was valued at USD 12.66 million in 2024 and is projected to grow at a CAGR of 5.8% during the forecast period. Minimally Invasive Glaucoma Surgery - MIGS Devices flourished in Brazil due to increasing healthcare awareness, improving medical infrastructure.
• Argentina's Minimally Invasive Glaucoma Surgery - MIGS Devices market had a market share of USD 4.97 million in 2024 and is projected to grow at a CAGR of 6.1% during the forecast period. Argentina's increasing healthcare awareness, improving medical infrastructure.
• Colombia Minimally Invasive Glaucoma Surgery - MIGS Devices market is projected to witness growth at a CAGR of 5.0% during the forecast period, with a market size of USD 2.63 million in 2024.
• Peru Minimally Invasive Glaucoma Surgery - MIGS Devices market is projected to witness growth at a CAGR of 5.4% during the forecast period, with a market size of USD 2.43 million in 2024.
• Chile Minimally Invasive Glaucoma Surgery - MIGS Devices market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD 2.13 million in 2024.
• The Rest of Latin America's Minimally Invasive Glaucoma Surgery - MIGS Devices market is projected to witness growth at a CAGR of 4.3% during the forecast period, with a market size of USD 4.76 million in 2024.

Middle East Minimally Invasive Glaucoma Surgery MIGS Devices Market Analysis

According to Cognitive Market Research, the global Minimally Invasive Glaucoma Surgery - MIGS Devices market size was estimated at USD 591.5 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 11.83 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2031..

• The GCC Countries Minimally Invasive Glaucoma Surgery - MIGS Devices market is projected to witness growth at a CAGR of 6.3% during the forecast period, with a market size of USD 5.06 million in 2024. Minimally Invasive Glaucoma Surgery - MIGS Devices sales flourish due to the advancements in healthcare infrastructure.
• The Egypt Minimally Invasive Glaucoma Surgery - MIGS Devices market is projected to witness growth at a CAGR of 5.8% during the forecast period, with a market size of USD 1.24 million in 2024.
• The South Africa Minimally Invasive Glaucoma Surgery - MIGS Devices market is projected to witness growth at a CAGR of 6.5% during the forecast period, with a market size of USD 1.87 million in 2024. Minimally Invasive Glaucoma Surgery - MIGS Devices sales flourished in South Africa due to advancements in healthcare infrastructure.
• The Turkey Minimally Invasive Glaucoma Surgery - MIGS Devices market is projected to witness growth at a CAGR of 5.0% during the forecast period, with a market size of USD 1.02 million in 2024.
• The Nigeria Minimally Invasive Glaucoma Surgery - MIGS Devices market is projected to witness growth at a CAGR of 4.6% during the forecast period, with a market size of USD 1.24 million in 2024.
• The Rest of the MEA Minimally Invasive Glaucoma Surgery - MIGS Devices market is projected to witness growth at a CAGR of 4.5% during the forecast period, with a market size of USD 1.40 million in 2024.

Minimally Invasive Glaucoma Surgery MIGS Devices Market Analysis

How are Segments Performing in the Global Minimally Invasive Glaucoma Surgery - MIGS Devices Market?

Minimally Invasive Glaucoma Surgery - MIGS Devices Market Surgery Segment Analysis

According to Cognitive Market Research, The segment of MIGS procedures performed for glaucoma in conjunction with cataract dominates the market due to its dual-treatment advantage. Patients undergoing cataract surgery often require intraocular pressure (IOP) management, making MIGS devices an efficient add-on procedure during cataract surgery. This approach reduces surgical time, minimizes risks, and eliminates the need for separate procedures, making it highly appealing for both patients and surgeons.

The stand-alone glaucoma segment is witnessing the fastest growth, driven by the rising focus on early-stage glaucoma management. Patients who do not require cataract surgery but suffer from elevated IOP are increasingly opting for stand-alone MIGS procedures due to their minimally invasive nature and shorter recovery times. The growing awareness of glaucoma’s risks and the availability of advanced MIGS devices tailored for isolated glaucoma treatment have further fueled demand.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Minimally Invasive Glaucoma Surgery MIGS Devices Industry. Request a Free Sample PDF!

Minimally Invasive Glaucoma Surgery - MIGS Devices Market Target Segment Analysis

According to Cognitive Market Research, the trabecular meshwork segment dominates the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market due to its widespread use in lowering intraocular pressure (IOP) in glaucoma patients. This target area is highly preferred as it effectively addresses resistance in the natural aqueous humor outflow pathway, which is a primary cause of glaucoma. Devices targeting the trabecular meshwork are known for their safety, efficacy, and ease of implantation, making them popular among surgeons.

The suprachoroidal space segment is the fastest-growing in the MIGS Devices Market, driven by advancements in technologies that target this area for enhanced aqueous humor drainage. This approach provides an alternative outflow pathway, making it particularly useful for patients who do not respond well to traditional treatments. Devices targeting the suprachoroidal space are gaining traction due to their ability to significantly reduce IOP with minimal invasiveness.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Minimally Invasive Glaucoma Surgery MIGS Devices Product Outlook: Segment Analysis

Minimally Invasive Glaucoma Surgery - MIGS Devices Market Product Segment Analysis

According to Cognitive Market Research, The MIGS stents dominate the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market due to their widespread adoption in clinical practice. These stents are designed to enhance aqueous humor drainage through the trabecular meshwork, effectively reducing intraocular pressure (IOP) in glaucoma patients. Their minimally invasive nature, combined with proven safety and efficacy, makes them a preferred choice for surgeons and patients alike.

The MIGS shunts segment is the fastest-growing category, driven by their innovative approach to managing glaucoma in patients with advanced disease stages or complex cases. Unlike stents, shunts offer an alternative drainage pathway, often targeting the suprachoroidal or subconjunctival space, which broadens their applicability. Recent advancements in shunt design have improved their performance and reduced associated risks, fueling their adoption.

• MIGS Stents
• MIGS Shunts
• Other (Trabectome/Micro-Implants/Micro-Catheters)

Minimally Invasive Glaucoma Surgery MIGS Devices End-use Outlook: Segment Analysis

Minimally Invasive Glaucoma Surgery - MIGS Devices Market End-use Segment Analysis

According to Cognitive Market Research, the Eye hospitals dominate the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market due to their comprehensive infrastructure and specialized expertise in handling complex glaucoma cases. These facilities often have advanced surgical equipment and a highly trained workforce, enabling them to perform a large volume of MIGS procedures. Eye hospitals are also the primary choice for patients seeking reliable treatment for glaucoma, as they offer a wide range of diagnostic and surgical services under one roof.

Ophthalmology clinics are the fastest-growing segment in the MIGS Devices Market, driven by the rising preference for personalized and easily accessible care. These clinics provide specialized glaucoma management services in a more convenient setting, appealing to patients seeking timely interventions. With advancements in MIGS devices and procedures, ophthalmology clinics can now perform minimally invasive surgeries without the need for extensive infrastructure, making them increasingly popular.

• Eye Hospitals
• Ophthalmology Clinics
• Outpatient Surgical Centers

Author's Detail

Ankita Sharma

Senior Research Analyst at Cognitive Market Research

LinkedIn

Profile

Ankita Sharma is a passionate and detail-driven market research professional with over 2.5 years of experience in qualitative research. With a sharp focus on client query handling and competitive intelligence, she has successfully led and delivered impactful research projects across diverse industry verticals. At the core of Ankita’s work is her ability to transform complex market data into actionable insights. She has spearheaded market intelligence initiatives by analyzing trends, evaluating competitor strategies, and mapping evolving market dynamics using a range of industry tools. Her approach combines precision with adaptability ensuring research outcomes are tailored to client-specific needs and strategic goals.
Ankita is also skilled in secondary research and product benchmarking, offering a holistic view of competitive landscapes. Her collaborative spirit and cross-functional coordination have helped refine research methodologies and maintain the highest quality standards in deliverables. Ankita’s commitment to excellence and client success makes her a valuable asset in the evolving world of market intelligence and business strategy.

Author's Conclusion